FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Denver Solutions, LLC dba Leiters Health(080586798)" | Ropivacaine Hydrochloride | 2 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-070 | 71449-070-25 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-124 | 71449-124-91 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-124 | 71449-124-83 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-126 | 71449-126-15 | Succinylcholine Chloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-105 | 71449-105-15 | Succinylcholine Chloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-44 | Bevacizumab | 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-22 | Bevacizumab | 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-43 | Bevacizumab | 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-98 | Bevacizumab | 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-098 | 71449-098-47 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-028 | 71449-028-68 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-029 | 71449-029-68 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-102 | 71449-102-36 | Cantharidin | 7 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-092 | 71449-092-45 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-092 | 71449-092-46 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-131 | 71449-131-11 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-131 | 71449-131-15 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 5 ug/1 mL; 3.75 mg/1 mL; .1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-072 | 71449-072-41 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-072 | 71449-072-82 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-013 | 71449-013-32 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-013 | 71449-013-05 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-104 | 71449-104-11 | Glycopyrrolate | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-018 | 71449-018-32 | Hydromorphone | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-068 | 71449-068-11 | Ketamine | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-068 | 71449-068-32 | Ketamine | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/7 mg; 4 mg/7 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/7 mg; 4 mg/7 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-691 | 69852-691-10 | Triamcinolone Acetonide | 50 mg/50 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-496 | 69852-496-10 | Triamcinolone Acetonide | 80 mg/80 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 10 mg/10 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-776 | 69852-776-10 | Dexamethasone Acetate Anhydrous | 8 mg/8 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 30 mg/30 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 80 mg/80 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 40 mg/40 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 40 mg/40 mg | 2023-2 | valid | 2026-11-08 | ||
| "Eagle Pharma Outsourcing, LLC(119019213)" | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 80 mg/80 mg | 2023-2 | valid | 2026-11-08 | ||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | .6 mg/.6 mL; 9 mg/.6 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .25 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 |